ロード中...
Species-Specific Actions of Incretin: From the Evolutionary Perspective
Two modes of incretin-based therapy, incretin mimetics (ie, glucagon-like peptide-1 (GLP-1) agonists) and incretin enhancers (ie, inhibitors of dipeptidyl peptidase IV (DPP-IV)), have recently been introduced into the clinical use. From the viewpoint of evolutionary endocrinology of GLP-1 and their...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Libertas Academica
2010
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3738467/ https://ncbi.nlm.nih.gov/pubmed/23946675 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/JCM.S5915 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|